Experimental breast cancer drug seems safe, effective for advanced disease
from HealthDay News
In an early trial, an experimental breast cancer drug stopped disease growth and shrank tumors by more than 30 percent in some patients. The pill, bemaciclib, was safe and well-tolerated by women with breast cancer that had spread, or metastasized, to other parts of the body, according to the results of this phase 1 trial.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063